Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study
Introduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific co...
Main Authors: | , , , , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2024-02-01
|
Series: | BMJ Open |
Online Access: | https://bmjopen.bmj.com/content/14/2/e084303.full |
_version_ | 1797257546516398080 |
---|---|
author | Roy P C Kessels Audrey Low Hugh Markus Anil Tuladhar Frank‐Erik de Leeuw Robin G Morris Ziad Mallat Niels P Riksen Daniel J Tozer Sanne van Winden Lupei Cai Marnix C Maas Meritxell Nus Anja van der Kolk Rowan Wolters |
author_facet | Roy P C Kessels Audrey Low Hugh Markus Anil Tuladhar Frank‐Erik de Leeuw Robin G Morris Ziad Mallat Niels P Riksen Daniel J Tozer Sanne van Winden Lupei Cai Marnix C Maas Meritxell Nus Anja van der Kolk Rowan Wolters |
author_sort | Roy P C Kessels |
collection | DOAJ |
description | Introduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific components of the immune response in SVD relating to disease progression. This could identify biomarkers of SVD progression, as well as potential therapeutic targets to inform the development and repurposing of drugs to reduce or prevent SVD, cognitive decline and vascular dementia.Methods and analysis INSVD is a prospective observational multicentre cohort study in individuals with symptomatic SVD. This longitudinal study combines comprehensive immunophenotyping of the peripheral blood immune compartment with advanced neuroimaging markers of SVD and BBB permeability. The main SVD marker of interest is white matter microstructure as determined by diffusion tensor imaging, a valuable marker of disease progression owing to its sensitivity to early alterations to white matter integrity. The research is being conducted in two sites—in the UK (Cambridge) and the Netherlands (Nijmegen)—with each site recruiting 100 participants (total n=200). Participants undergo clinical and cognitive assessments, blood draws, and brain MRI at baseline and 2-year follow-up.Ethics and dissemination This study received ethical approval from the local ethics boards (UK: East of England—Cambridge Central Research Ethics Committee (REC) ref: 22/EE/00141, Integrated Research Application System (IRAS) ID: 312 747. Netherlands: Medical Research Ethics Committee (MREC) Oost-Nederland, ref: 2022-13623, NL-number: NL80258.091.22). Written informed consent was obtained from all subjects before the study. Any participant-derived benefits resulting from this research, such as new insights into disease mechanisms or possible novel therapies, will be disseminated to study participants, patient groups and members of the public.Trial registration number NCT05746221. |
first_indexed | 2024-03-07T21:24:07Z |
format | Article |
id | doaj.art-9de6a34a9f7443a3934e4e2d8c33f96d |
institution | Directory Open Access Journal |
issn | 2044-6055 |
language | English |
last_indexed | 2024-04-24T22:39:22Z |
publishDate | 2024-02-01 |
publisher | BMJ Publishing Group |
record_format | Article |
series | BMJ Open |
spelling | doaj.art-9de6a34a9f7443a3934e4e2d8c33f96d2024-03-19T05:30:08ZengBMJ Publishing GroupBMJ Open2044-60552024-02-0114210.1136/bmjopen-2024-084303Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort studyRoy P C Kessels0Audrey Low1Hugh Markus2Anil Tuladhar3Frank‐Erik de Leeuw4Robin G Morris5Ziad Mallat6Niels P Riksen7Daniel J Tozer8Sanne van Winden9Lupei Cai10Marnix C Maas11Meritxell Nus12Anja van der Kolk13Rowan Wolters14Vincent Van Gogh Instituut, Venray, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsInstitute of Psychiatry, Psychology and Neuroscience (IoPPN), King`s College London, London, UKThe Victor Phillip Dahdaleh Heart and Lung Research Institute, Section of Cardiorespiratory Medicine, Department of Medicine, University of Cambridge Medicine, Cambridge, UKDepartment of Internal Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsDepartment of Clinical Neurosciences, University of Cambridge, Cambridge, UKDepartment of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The NetherlandsDivision of Cardiovascular Medicine, Department of Medicine, University of Cambridge, Cambridge, UKDepartment of Radiology and Nuclear Medicine, Radboudumc, Nijmegen, The NetherlandsDepartment of Neurology, Radboudumc, Nijmegen, The NetherlandsIntroduction The INflammation and Small Vessel Disease (INSVD) study aims to investigate whether peripheral inflammation, immune (dys)regulation and blood–brain barrier (BBB) permeability relate to disease progression in cerebral small vessel disease (SVD). This research aims to pinpoint specific components of the immune response in SVD relating to disease progression. This could identify biomarkers of SVD progression, as well as potential therapeutic targets to inform the development and repurposing of drugs to reduce or prevent SVD, cognitive decline and vascular dementia.Methods and analysis INSVD is a prospective observational multicentre cohort study in individuals with symptomatic SVD. This longitudinal study combines comprehensive immunophenotyping of the peripheral blood immune compartment with advanced neuroimaging markers of SVD and BBB permeability. The main SVD marker of interest is white matter microstructure as determined by diffusion tensor imaging, a valuable marker of disease progression owing to its sensitivity to early alterations to white matter integrity. The research is being conducted in two sites—in the UK (Cambridge) and the Netherlands (Nijmegen)—with each site recruiting 100 participants (total n=200). Participants undergo clinical and cognitive assessments, blood draws, and brain MRI at baseline and 2-year follow-up.Ethics and dissemination This study received ethical approval from the local ethics boards (UK: East of England—Cambridge Central Research Ethics Committee (REC) ref: 22/EE/00141, Integrated Research Application System (IRAS) ID: 312 747. Netherlands: Medical Research Ethics Committee (MREC) Oost-Nederland, ref: 2022-13623, NL-number: NL80258.091.22). Written informed consent was obtained from all subjects before the study. Any participant-derived benefits resulting from this research, such as new insights into disease mechanisms or possible novel therapies, will be disseminated to study participants, patient groups and members of the public.Trial registration number NCT05746221.https://bmjopen.bmj.com/content/14/2/e084303.full |
spellingShingle | Roy P C Kessels Audrey Low Hugh Markus Anil Tuladhar Frank‐Erik de Leeuw Robin G Morris Ziad Mallat Niels P Riksen Daniel J Tozer Sanne van Winden Lupei Cai Marnix C Maas Meritxell Nus Anja van der Kolk Rowan Wolters Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study BMJ Open |
title | Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study |
title_full | Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study |
title_fullStr | Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study |
title_full_unstemmed | Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study |
title_short | Immune regulation and blood–brain barrier permeability in cerebral small vessel disease: study protocol of the INflammation and Small Vessel Disease (INSVD) study – a multicentre prospective cohort study |
title_sort | immune regulation and blood brain barrier permeability in cerebral small vessel disease study protocol of the inflammation and small vessel disease insvd study a multicentre prospective cohort study |
url | https://bmjopen.bmj.com/content/14/2/e084303.full |
work_keys_str_mv | AT roypckessels immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT audreylow immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT hughmarkus immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT aniltuladhar immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT frankerikdeleeuw immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT robingmorris immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT ziadmallat immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT nielspriksen immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT danieljtozer immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT sannevanwinden immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT lupeicai immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT marnixcmaas immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT meritxellnus immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT anjavanderkolk immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy AT rowanwolters immuneregulationandbloodbrainbarrierpermeabilityincerebralsmallvesseldiseasestudyprotocoloftheinflammationandsmallvesseldiseaseinsvdstudyamulticentreprospectivecohortstudy |